AbbVie is reportedly trying to buy a biotech company that is developing a promising atopic dermatitis drug for $10.9 billion in cash, according to a Financial Times report.
Source link
Trending
- No real spike in petrol, diesel prices in India despite global crude oil market volatility: Hardeep Singh Puri
- Fed Chair Kevin Warsh wants to get inflation under control. That could be bad news for home buyers seeking lower mortgage rates.
- BBC sees destroyed villages in Israeli-occupied southern Lebanon
- SOP released to conserve sea turtles across 36 islands of Lakshadweep | India News
- NFL fans react to Fernando Mendoza’s first meeting with Raiders brass at 2026 combine
- ‘Food like prasad’: Farah Khan discovers ‘Panch-Tatva’ chaat at astrologer Jai Madaan’s Delhi mansion | Health News
- This simple twist could bring quantum computers closer to reality
- Sun Pharma Clarifies No Operational Impact from Arrest of Independent Director Gautam Doshi
